Study Summary
This trial will allow people who haven't been helped by other medications to keep using a therapy that uses sound waves to target the nerves around the kidney.
- Resistant Hypertension
- Cardiovascular Disease
- Vascular Disease
- High Blood Pressure
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 5 Secondary · Reporting Duration: From Baseline to Months 2, 6, 12, 24, 36, 48, and 60 post procedure
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Renal Denervation
1 of 1
Experimental Treatment
300 Total Participants · 1 Treatment Group
Primary Treatment: Renal Denervation · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Texas | 100.0% |
What site did they apply to?
| The University of Texas Health Sciences Center at Houston | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Why did patients apply to this trial?
- "Help treat high blood pressure"
How many prior treatments have patients received?
| 1 | 100.0% |
- Azizi, Michel, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P Reilly, Terry Levy, Lars C Rump, et al.. 2021. “Ultrasound Renal Denervation for Hypertension Resistant to a Triple Medication Pill (RADIANCE-HTN TRIO): A Randomised, Multicentre, Single-blind, Sham-controlled Trial”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(21)00788-1.
- 2022. "RADIANCE Continued Access Protocol". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05017935.
Frequently Asked Questions
Is it possible to join the research cohort?
"To partake in this research, potential participants must have cardiovascular diseases and be aged between 18-75 years. According to the study, 300 individuals need to enrol." - Anonymous Online Contributor
Are there opportunities for new participants to join this research endeavor?
"This medical experiment is actively recruiting, as evidenced by recent updates to the clinicaltrials.gov page which notes that it was first posted on May 4th 2022 and last modified November 23rd of this year." - Anonymous Online Contributor
Does this research encompass those who are under thirty years of age?
"This trial only admits participants aged 18 to 75. For those who are underaged, there are 82 clinical trials that may be suitable and for seniors (over 65), 1059 medical studies might provide the necessary treatment." - Anonymous Online Contributor
How many participants are included in this experiment?
"In order to conduct the trial, 300 participants that meet the inclusion criteria need to be recruited. ReCor Medical Inc., is overseeing this experiment across multiple sites including The Brigham and Women's Hospital in Massachusetts and Medical University of South Carolina in Charleston." - Anonymous Online Contributor
Is this medical trial being conducted extensively in Canadian hospitals?
"This medical study is being conducted in The Brigham and Women's Hospital, Medical University of South Carolina, Swedish Health Services as well as 12 other sites." - Anonymous Online Contributor